Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03484039 · ClinicalTrials.gov registry record · NA
Incorporating Multidimensional Psychosocial Interventions Improves the Well-being of Individuals With Epilepsy
A NA study, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 332
- Enrollment target
NCT03484039: Completed NA study, sponsored by University of Florida.
NCT03484039 is a NA study that has completed, run by University of Florida. The registered enrollment target is 332 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (76% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03484039, a NA study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 332 participants
- Enrollment target
Study Summary
The purpose of this study is to incorporate multidimensional self-management programs into the routine care of epilepsy patients. Consenting patients will enroll in one of four interventions that help improve medication adherence, increase seizure awareness and documentation, improve memory and deal with stress and depression.
Primary Outcome
This is a well-validated measure of quality of life for epilepsy patients. The unit of measure is a composite score ranging from 0-100 with higher scores indicating better quality of life.
Interventions
- BEHAVIORAL Stress Management
- BEHAVIORAL Medication Adherence
- BEHAVIORAL Seizure Documentation
- BEHAVIORAL Memory Improvement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 332 participants |
| Start Date | 2018-06-06 |
| Est. Completion | 2020-02-18 |
| Phase | NA |
What the finished NCT03484039 record still lists
NCT03484039 is an interventional study that assigns participants to a tested intervention. The registered 332 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (76% lower).
The record links to 0 conditions, and to 4 interventions - of which Stress Management is the first listed.
NCT03484039 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03484039 about?
NCT03484039 is a clinical study titled "Incorporating Multidimensional Psychosocial Interventions Improves the Well-being of Individuals With Epilepsy". The purpose of this study is to incorporate multidimensional self-management programs into the routine care of epilepsy patients. Consenting patients will enroll in one of four interventions that help improve medication adherence, increase seizure awareness and documentation, improve memory and deal...
What is the current status of trial NCT03484039?
This trial is currently completed. It is a NA study. The enrollment target is 332 participants. The study started on 2018-06-06. Estimated completion is 2020-02-18.
What interventions are being tested in trial NCT03484039?
The interventions under investigation include: Stress Management (BEHAVIORAL), Medication Adherence (BEHAVIORAL), Seizure Documentation (BEHAVIORAL), Memory Improvement (BEHAVIORAL).
Who is sponsoring clinical trial NCT03484039?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03484039's enrollment target sits among peer trials
332 306th of 2000 higher than 1,694 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174121 · 332 participants · Phase 2
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
- NCT02605785 · 332 participants · NA
A Molecular Anatomic Imaging Analysis of Tau in Progressive Supranuclear Palsy
- NCT04894006 · 332 participants · NA
Dementia Family Caregiver Study
- NCT05130606 · 332 participants · NA
CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI